Search
  • 網站搜尋
亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。
返回搜索結果

Anti-O-linked N-acetylglucosamine (O-GlcNAc) Monoclonal Antibodies (23 lines)


詳細技術說明

These mouse monoclonalantibodies were generated against a synthetic three-component O-linkedN-acetylglucosamine (O-GlcNAc) immunogen and recognizes GluNAcpepetide/O-GlcNAc. Suitable for ELISA and Western Blot applications. The study of O-GlcNAc,a ubiquitous translation and transcription regulator which is found in a widevariety of proteins, is of great relevance to multiple chronic human andveterinary diseases. These include diabetes (and its effects in the heart,kidneys and eyes), cardiovascular disease, neurodegenerative disordersinvolving both plaque and tangle formation, inflammatory processes, liverdisease, fibrosis, metabolic disorders and cancer. There is fast growingcollection of evidence that O-GlcNAcylation plays a pivotal role in epigenetics.This  a 23 Mab panel was developedspecifically to study the diverse roles of O-GlcNAc and that can be employedfor detection, isolation, and site localization. For details on antigenstrategy, please consult: Chin Fen Teo, et al., Nat Chem Biol. 2010 May; 6(5):338-343. doi:10.1038/nchembio.338 (see link below).


國家/地區

美國

欲了解更多信息,請點擊 這裡
Business of IP Asia Forum
桌面版